RLX trades margin for scale in European distribution
- A July 2026 controlling investment in a Western European distributor will drive revenue scale starting in Q3.
- The distribution business will structurally lower percentage gross margins despite growing total profit dollars.
- Management expects Mainland China sales to be broadly flat for the year due to slow regulatory approvals.
- The company is building a Southeast Asia manufacturing hub for modern oral pouches and tariff relief.
- The U.K. generational cigarette ban protects e-vapor as a legal adult nicotine channel.
A global distribution bet
RLX used to look mostly like a China e-vapor company. That has changed. After a non-compete ended, the company pushed hard overseas. International sales accounted for 76.5% of revenue in Q4 2025 and continue to drive growth today.
The bull case is that RLX is becoming a scale player in regulated nicotine alternatives. In July 2026, the company made a controlling investment in a major Western European physical and digital distributor. This buys direct retail access and shelf space. A new Southeast Asia manufacturing hub will also improve tariff positioning and support new product lines like modern oral pouches.
Regulation is the swing factor. The U.K. Tobacco and Vapes Act became law in April 2026, banning cigarette sales to future generations but keeping the adult e-vapor age at 18. RLX compliance infrastructure can turn tightening global rules into a structural advantage.
The bear case centers on margin compression and domestic weakness. The European distribution business operates on structurally lower percentage gross margins. Meanwhile, the China market is expected to remain flat year over year due to slow administrative approvals and illegal products.
From brand seller to marketplace operator
RLX designs, develops, makes, and distributes e-vapor products. It sells devices and pods across price levels, then uses brand, retail partners, and local rules to win adult users market by market.
The model is getting more integrated. The fully operational Nexus facility brings R&D and manufacturing together. To support multi-category expansion and reduce trade friction, RLX is currently constructing a new manufacturing hub in Southeast Asia.
Europe changed the shape of the company. In July 2026, RLX cemented its shift away from traditional wholesaling by making a controlling investment in a leading Western European B2B and FMCG physical distributor. This transforms RLX into an open, multi-brand marketplace operator.
This model can break if rules turn against the category, if the lower-margin distribution business drags down overall profitability too much, or if cheaper illegal products keep taking share in China.
Pods, big puffs, and oral pouches
Cartridge systems
These are the core refill or cartridge products that built the brand, covering low to high price tiers.
Large-volume compliant disposables
Big Puff products target users moving away from small-puff disposables as bans take effect. The shift lifts volume but can lower price per liquid volume.
Modern oral products
RLX is accelerating its commercialization of modern oral nicotine pouches, with specialized production lines being built in its new Southeast Asia hub.
Heated tobacco
Management holds extensive patents for heated tobacco but awaits optimal conditions for launch. There is no immediate launch plan.
Mostly outside China now
The exact mix shown uses Q4 2025 figures when international sales reached 76.5% of revenue. The European segment is slated for a massive scale-up starting in Q3 2026 due to the new distribution consolidation.
What could go wrong
Distribution margins compress returns
High impact · High oddsThe July 2026 European distribution acquisition operates at a structurally lower percentage gross margin than proprietary brand operations. This shift could pressure headline ratios and investor sentiment.
China approvals stay stalled
Medium impact · High oddsProcedural timelines for product approvals in China have become conservative. Management expects domestic sales to be broadly flat for 2026, limiting total company growth.
Illegal China products keep winning
High impact · High oddsIllegal e-vapor products have heavily proliferated in China. If enforcement does not clear the market, the domestic business will remain structurally impaired.
Europe changes the rules again
High impact · Medium oddsThe U.K. law is favorable for e-vapor, but proposed regulations include plain packaging, restricted flavors, and display limits. Harsh new rules could slow RLX's fastest growth area.
In one breath
What does RLX Technology do?
RLX makes e-vapor products, including cartridge systems and disposables, and is expanding into modern oral nicotine pouches. It also operates a large distribution network in Europe.
Why is RLX focused on international markets?
China has been hurt by illegal products and slow regulatory approvals. International sales now make up the vast majority of revenue, and RLX recently acquired a major distributor in Western Europe.
Is U.K. regulation good or bad for RLX?
For now, it looks more helpful than harmful. The U.K. law bans future cigarette sales by birth year but keeps adult e-vapor sales legal, which pushes out non-compliant sellers.
Sources and research notes
This page combines Finn's company research with public filings and other cited materials. The thesis is reviewed when material company information changes; Finn Scores use the latest available scoring data.
- Thesis reviewed
- August 23, 2026
- Score data
- September 27, 2026
- Reviewed by
- Shivam Bharuka
Comparable Tobacco companies
Companies near RLX Technology Inc. in Finn's Tobacco industry ranking.
